This article is from the source 'bbc' and was first published or seen on . It will not be checked again for changes.
You can find the current article at its original source at http://news.bbc.co.uk/go/rss/-/1/hi/health/6768427.stm
The article has changed 15 times. There is an RSS feed of changes available.
| Version 9 | Version 10 |
|---|---|
| Panel endorses girls' cancer jab | Panel endorses girls' cancer jab |
| (about 1 hour later) | |
| All girls aged between 12 and 13 in the UK should be vaccinated against the virus that causes cervical cancer, a government panel has recommended. | All girls aged between 12 and 13 in the UK should be vaccinated against the virus that causes cervical cancer, a government panel has recommended. |
| The government in England said while it accepted the advice "in principle", it would have to decide if the programme was financially viable. | The government in England said while it accepted the advice "in principle", it would have to decide if the programme was financially viable. |
| It is thought that vaccinating against human papillomavirus (HPV) could save hundreds of lives in the UK each year. | It is thought that vaccinating against human papillomavirus (HPV) could save hundreds of lives in the UK each year. |
| But experts say it could be 20 years before the first benefits are seen. | But experts say it could be 20 years before the first benefits are seen. |
| This is a huge step forward in preventing cancer Dr David SalisburyDepartment of Health class="" href="/1/hi/health/6223000.stm">Q&A: Cervical cancer vaccine | |
| It will also prove expensive, costing around £250 for three doses over six months. | It will also prove expensive, costing around £250 for three doses over six months. |
| However, campaigners say it represents value for money given how effective it is in combating HPV, which is held responsible for around 70% of cervical cancer cases. | However, campaigners say it represents value for money given how effective it is in combating HPV, which is held responsible for around 70% of cervical cancer cases. |
| The disease kills 274,000 women worldwide every year, including 1,120 in the UK. | The disease kills 274,000 women worldwide every year, including 1,120 in the UK. |
| "This is a huge step forward in preventing cancer," said Dr David Salisbury, Director of Immunisation at the Department of Health, after the recommendation was made. | "This is a huge step forward in preventing cancer," said Dr David Salisbury, Director of Immunisation at the Department of Health, after the recommendation was made. |
| There are two vaccine possibilities: Gardasil, made by Merck and Sanofi Pasteur, has already been approved in 76 countries, while Cervarix is expected to be launched in Europe later this year. | There are two vaccine possibilities: Gardasil, made by Merck and Sanofi Pasteur, has already been approved in 76 countries, while Cervarix is expected to be launched in Europe later this year. |
| Pre-emptive strike | Pre-emptive strike |
| The Joint Committee on Vaccination and Immunisation (JCVI) examined the evidence surrounding the vaccines before concluding that 12-and 13-year-old girls should all be immunised. | The Joint Committee on Vaccination and Immunisation (JCVI) examined the evidence surrounding the vaccines before concluding that 12-and 13-year-old girls should all be immunised. |
| The main benefits won't be seen until decades down the line Dr David Elliman Cervical cancer | The main benefits won't be seen until decades down the line Dr David Elliman Cervical cancer |
| But it did not, as some had hoped, call for a "catch-up" programme which would include all those up to the age of 16. | But it did not, as some had hoped, call for a "catch-up" programme which would include all those up to the age of 16. |
| The vaccine is most effective when it is administered to girls before they become sexually active. | The vaccine is most effective when it is administered to girls before they become sexually active. |
| Some have expressed concerns that providing a jab to protect against a sexually transmitted infection to children at a young age might encourage promiscuity. | Some have expressed concerns that providing a jab to protect against a sexually transmitted infection to children at a young age might encourage promiscuity. |
| But in a Manchester University study of parents' attitudes, only a minority of those asked expressed concern about the sexual implications. The report concluded that most - if convinced the jab was safe and effective - would support the vaccine. | But in a Manchester University study of parents' attitudes, only a minority of those asked expressed concern about the sexual implications. The report concluded that most - if convinced the jab was safe and effective - would support the vaccine. |
| In any event, parents would have the final say as to whether their child received the injection. | In any event, parents would have the final say as to whether their child received the injection. |
| Strings attached | Strings attached |
| The Tories have accused the government of dragging its feet on the issue, noting that many countries had already approved the vaccine. | The Tories have accused the government of dragging its feet on the issue, noting that many countries had already approved the vaccine. |
| Switzerland gave it the green light this week, following on the heels of Austria, Germany, Italy, France, Norway, Luxembourg and Belgium. It has also been approved in Australia and several US states. | Switzerland gave it the green light this week, following on the heels of Austria, Germany, Italy, France, Norway, Luxembourg and Belgium. It has also been approved in Australia and several US states. |
| Following the announcement from the JCVI, health minister Caroline Flint said she was "delighted to announce that we intend, in principle, to introduce an HPV vaccine into the national immunisation programme". | Following the announcement from the JCVI, health minister Caroline Flint said she was "delighted to announce that we intend, in principle, to introduce an HPV vaccine into the national immunisation programme". |
| But there were conditions, a Department of Health statement added. The programme would have to undergo an "independent peer review of the cost-benefit analysis", and funding for it would be "considered in the context of the Comprehensive Spending Review". | But there were conditions, a Department of Health statement added. The programme would have to undergo an "independent peer review of the cost-benefit analysis", and funding for it would be "considered in the context of the Comprehensive Spending Review". |
| The vaccine costs more than all the immunisations each child receives put together, said Dr David Elliman, a consultant In Community Child Health at Great Ormond Street Hospital For Children. | The vaccine costs more than all the immunisations each child receives put together, said Dr David Elliman, a consultant In Community Child Health at Great Ormond Street Hospital For Children. |
| "It will be a big, long-term investment," he said. "The main benefits won't be seen until decades down the line, as these girls become women, but we will, eventually, get our money back." | "It will be a big, long-term investment," he said. "The main benefits won't be seen until decades down the line, as these girls become women, but we will, eventually, get our money back." |